Skip to main content
    M

    MetLife Inc (MET)

    Official site

    FINANCIAL SERVICES • INSURANCE - LIFE • NYSE

    $101.45
    -1.20 (-1.16%)

    Market Cap: $64.51B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MetLife Inc (MET) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect MetLife (MET) to earn $10.23 per share in the fiscal year ending Dec 31, 2026, on revenue of $79.45B. Of 18 analysts, 13 rate the stock Buy or Strong Buy, 4 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 15 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 18 ratings average 2.11, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 72% of the ratings.

    RatingAnalystsShare
    Strong Buy527.8%
    Buy844.4%
    Hold422.2%
    Sell00.0%
    Strong Sell15.6%
    Consensus
    Buy
    Total analysts
    18

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 9.3% and revenue estimates rise 4.5%.

    Fiscal year ending Dec 31, 2026
    $10.23
    EPS consensus, revenue $79.45B
    Fiscal year ending Dec 31, 2027
    $11.18
    EPS consensus, revenue $83.03B
    Next report
    Feb 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$10.23$10.02 to $10.4817$79.45B$78.59B to $80.61B8
    Dec 31, 2027$11.18$10.90 to $11.6517$83.03B$80.20B to $84.83B8

    Quarterly Estimates

    The EPS consensus falls from $2.65 for the quarter ending Dec 31, 2026 to $2.58 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.65$2.36 to $3.0018$20.89B$19.53B to $22.97B8
    Mar 31, 2027$2.58$2.39 to $2.7811$20.45B$20.09B to $20.66B3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 24 upward and 2 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026150
    Fiscal year ending Dec 31, 202762
    Quarter ending Mar 31, 202730

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.8% from $9.95.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$10.23$10.22$10.15$10.00$9.95+2.9%
    Fiscal year ending Dec 31, 2027$11.18$11.16$11.15$11.13$11.09+0.8%
    Quarter ending Mar 31, 2027$2.58$2.58$2.58$2.57$2.55+1.2%

    Frequently Asked Questions About MET

    What is the MET stock forecast?

    Consensus analyst estimates put MetLife's EPS at $10.23 for the fiscal year ending Dec 31, 2026, on revenue of $79.45B. The consensus rating from 18 analysts is Buy.

    How do analysts rate MET stock?

    Of 18 analysts covering MetLife, 5 rate it Strong Buy, 8 Buy, 4 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from MET next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $10.23, with estimates from $10.02 to $10.48 from 17 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $11.18, with estimates from $10.90 to $11.65 from 17 analysts.

    What revenue do analysts expect from MetLife next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $79.45B, with estimates from $78.59B to $80.61B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $83.03B, with estimates from $80.20B to $84.83B.

    How many analysts cover MET?

    18 analysts rate MetLife stock, and 17 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.